rs17145653
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000378444.9(BCOR):c.1650C>T(p.Thr550=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00877 in 1,211,722 control chromosomes in the GnomAD database, including 37 homozygotes. There are 3,393 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0079 ( 5 hom., 263 hem., cov: 25)
Exomes 𝑓: 0.0089 ( 32 hom. 3130 hem. )
Consequence
BCOR
ENST00000378444.9 synonymous
ENST00000378444.9 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.28
Genes affected
BCOR (HGNC:20893): (BCL6 corepressor) The protein encoded by this gene was identified as an interacting corepressor of BCL6, a POZ/zinc finger transcription repressor that is required for germinal center formation and may influence apoptosis. This protein selectively interacts with the POZ domain of BCL6, but not with eight other POZ proteins. Specific class I and II histone deacetylases (HDACs) have been shown to interact with this protein, which suggests a possible link between the two classes of HDACs. Several transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome Y.[provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant X-40073696-G-A is Benign according to our data. Variant chrX-40073696-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 95765.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-40073696-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-3.28 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00787 (894/113567) while in subpopulation NFE AF= 0.0117 (623/53427). AF 95% confidence interval is 0.0109. There are 5 homozygotes in gnomad4. There are 263 alleles in male gnomad4 subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCOR | NM_001123385.2 | c.1650C>T | p.Thr550= | synonymous_variant | 4/15 | ENST00000378444.9 | NP_001116857.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCOR | ENST00000378444.9 | c.1650C>T | p.Thr550= | synonymous_variant | 4/15 | 1 | NM_001123385.2 | ENSP00000367705 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00788 AC: 894AN: 113514Hom.: 5 Cov.: 25 AF XY: 0.00738 AC XY: 263AN XY: 35648
GnomAD3 genomes
AF:
AC:
894
AN:
113514
Hom.:
Cov.:
25
AF XY:
AC XY:
263
AN XY:
35648
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00551 AC: 1010AN: 183300Hom.: 5 AF XY: 0.00540 AC XY: 366AN XY: 67750
GnomAD3 exomes
AF:
AC:
1010
AN:
183300
Hom.:
AF XY:
AC XY:
366
AN XY:
67750
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00886 AC: 9731AN: 1098155Hom.: 32 Cov.: 33 AF XY: 0.00861 AC XY: 3130AN XY: 363515
GnomAD4 exome
AF:
AC:
9731
AN:
1098155
Hom.:
Cov.:
33
AF XY:
AC XY:
3130
AN XY:
363515
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00787 AC: 894AN: 113567Hom.: 5 Cov.: 25 AF XY: 0.00736 AC XY: 263AN XY: 35711
GnomAD4 genome
AF:
AC:
894
AN:
113567
Hom.:
Cov.:
25
AF XY:
AC XY:
263
AN XY:
35711
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 28, 2012 | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 03, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 30, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Oculofaciocardiodental syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at